Different free prostate-specific antigen to total prostate-specific antigen ratios using three detecting systems

被引:6
|
作者
Huang, Hui-Qing [1 ,2 ]
Zhang, Yan [1 ]
Xu, Hua-Guo [1 ]
机构
[1] Nanjing Med Univ, Dept Lab Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[2] Oriental & Foreign Related Hosp, Dept Lab Med, Lianyungang, Peoples R China
基金
中国国家自然科学基金;
关键词
immunoenzymatic assay; prostate-specific antigen; reversed ratio;
D O I
10.1002/jcla.22231
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BackgroundProstate-specific antigen (PSA) is used as an indicative marker of a pathologic condition of the prostate, and the ratio of free PSA (fPSA) to total PSA (tPSA) helps to distinguish benign prostatic hyperplasia (BPH) from prostate cancer (PCa). In this study, we present some reversed ratios of fPSA to tPSA and analyze the possible mechanism. MethodsUsing the UniCel DxI800 Access Immunoassay System, eight reversed fPSA to tPSA ratios were obtained, and then these samples were retested with an Abbott Architect i2000 Immunoassay Analyser and Cobas e602. ResultsFour of the eight reversed ratios kept a ratio >1 using Abbott Architect i2000, and seven of them turned into a ratio <1 using Cobas e602. ConclusionIn consideration of the assay these three detecting systems apply, the possible reason of the reversed ratios can be heterophile antibodies. To get accurate reason, further study is required.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen
    Morgan, TO
    McLeod, DG
    Leifer, ES
    Murphy, GP
    Moul, JW
    UROLOGY, 1996, 48 (6A) : 76 - 80
  • [22] Activity does not affect free and total prostate-specific antigen levels but lowers the free-to-total prostate-specific antigen ratio
    Ulman, C
    Buyukyazi, G
    Taneli, F
    Uyanik, BS
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2004, 32 (06) : 583 - 589
  • [23] Prostate-specific antigen velocity and repeated measures of prostate-specific antigen
    Carter, HB
    Pearson, JD
    UROLOGIC CLINICS OF NORTH AMERICA, 1997, 24 (02) : 333 - &
  • [24] Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels
    Richard M. Hoffman
    David L. Clanon
    Benjamin Littenberg
    Joseph J. Frank
    John C. Peirce
    Journal of General Internal Medicine, 2000, 15 : 739 - 748
  • [25] Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels
    Hoffman, RM
    Clanon, DL
    Littenberg, B
    Frank, JJ
    Peirce, JC
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (10) : 739 - 748
  • [26] Kinetics of postbiopsy levels of serum free prostate-specific antigen and percent free prostate-specific antigen
    Lechevallier, E
    Eghazarian, C
    Ortega, JC
    Daniel, L
    Roux, F
    Thirion, X
    Coulange, C
    UROLOGY, 1999, 53 (04) : 731 - 735
  • [27] Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis
    Gorday, William
    Sadrzadeh, Hossein
    de Koning, Lawrence
    Naugler, Christopher T.
    CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1230 - 1234
  • [28] Free and total prostate-specific antigen in a screened population
    Bangma, CH
    Kranse, R
    Blijenberg, BG
    Schroder, FH
    BRITISH JOURNAL OF UROLOGY, 1997, 79 (05): : 756 - 762
  • [29] Prostate-specific antigen
    Huland, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 121 (21) : 710 - 710
  • [30] Prostate-specific antigen
    Brawer, MK
    SEMINARS IN SURGICAL ONCOLOGY, 2000, 18 (01): : 3 - 9